−0.9169USD
−6.14 MUSD
10.49 M
About Soligenix, Inc.
Sector
CEO
Christopher J. Schaber
Headquarters
Princeton
Website
Employees (FY)
15
Founded
1987
ISIN
US8342235053
FIGI
BBG000FVMHG5
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. The Specialized BioTherapeutics segment focuses on the development of a novel photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Public Health Solutions segment consists of active development programs for RiVax, a ricin toxin vaccine candidate, and SGX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease. The company was founded in 1987 and is headquartered Princeton, NJ.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SNGX is 0.4100 USD — it has decreased by 5.81% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Soligenix, Inc. stocks are traded under the ticker SNGX.
Soligenix, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
SNGX stock is 12.42% volatile and has beta coefficient of 0.69. Check out the list of the most volatile stocks — is Soligenix, Inc. there?
SNGX earnings for the last quarter are −0.16 USD per share, whereas the estimation was −0.14 USD resulting in a −14.29% surprise. The estimated earnings for the next quarter are −0.20 USD per share. See more details about Soligenix, Inc. earnings.
Soligenix, Inc. revenue for the last quarter amounts to 100.00 K USD despite the estimated figure of 200.00 K USD. In the next quarter revenue is expected to reach 200.00 K USD.
Yes, you can track Soligenix, Inc. financials in yearly and quarterly reports right on TradingView.
SNGX stock has risen by 0.05% compared to the previous week, the month change is a 35.94% fall, over the last year Soligenix, Inc. has showed a 77.09% decrease.
SNGX net income for the last quarter is −1.82 M USD, while the quarter before that showed −1.66 M USD of net income which accounts for −9.45% change. Track more Soligenix, Inc. financial stats to get the full picture.
Today Soligenix, Inc. has the market capitalization of 4.58 M, it has decreased by 10.28% over the last week.
No, SNGX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SNGX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Soligenix, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 15.00 employees. See our rating of the largest employees — is Soligenix, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Soligenix, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Soligenix, Inc. stock shows the strong sell signal. See more of Soligenix, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.